Nickel North samples up to 0.644 g/t Pd at Hawk Ridge
Soil assays offer geological hope while past-due multi-million dollar debt threatens corporate survival.
The most recent news release (January 5, 2026) reports laboratory assay results for 205 soil samples at the Hawk Ridge project in Northern Quebec. These results confirm and expand upon preliminary XRF data from 2022. Key highlights include palladium (Pd) values up to 0.644 g/t, gold (Au) up to 0.449 g/t, and copper (Cu) up to 1.04%. The company indicates a strong correlation between copper and palladium, which will be used as a "vectoring tool" for the 2026 drilling season. These results follow a period of relative inactivity where samples collected in 2022 were only recently "recovered" and sent for certified lab analysis in late 2025.
The impact of the latest news is minor and secondary to the company’s structural financial risks. While the confirmation of high-grade copper and palladium in soil is a technical positive for exploration targeting, soil samples are not a substitute for drill core and do not provide a resource update.
The material reality for Nickel North is defined by its balance sheet rather than its soil chemistry. As of September 30, 2025, the company had a working capital deficit of nearly $3 million. While the $1.5 million private placement closed in October 2025 provided a temporary lifeline, it significantly diluted shareholders (adding 60 million shares) and does not fully resolve the $2.2 million convertible debenture that appears to be past its 2023 maturity date. The termination of the option agreement with 1844 Resources in September 2025 is a significant blow, as it forces Nickel North to fund 100% of the exploration costs on its own with limited cash.
Nickel North Exploration is a Canadian junior explorer focused on the Hawk Ridge Cu-Ni-PGE-Co project in Northern Quebec. The project is a district-scale land package (approx. 179 km2) situated near tidewater. It contains known sulfide mineralization zones (Hope Advance Main, Hope Advance North, Gamma, Falco, and Lucille). The project has been stagnant for several years, as evidenced by the fact that 2022 samples were not assayed until late 2025.